FDA Advocacy

FDA Meeting – Emergency Use Authorization of the Johnson & Johnson/Janssen Biotech Inc. COVID-19 Vaccine

By Sarah Christopherson | Feb 26, 2021 | Comments Off on FDA Meeting – Emergency Use Authorization of the Johnson & Johnson/Janssen Biotech Inc. COVID-19 Vaccine

Testimony Delivered to the Vaccines and Related Biological Products Advisory Committee

Your Questions About the New COVID-19 Vaccines – Answered

By Sarah Christopherson | Dec 14, 2020 | Comments Off on Your Questions About the New COVID-19 Vaccines – Answered

How safe are the vaccines? How effective? Were they tested in people like me? Was the approval process influenced by political pressure? Here’s what we know.

FDA Meeting – Emergency Use Authorization of the Pfizer-BioNTech COVID-19 Vaccine

By Sarah Christopherson | Dec 10, 2020 | Comments Off on FDA Meeting – Emergency Use Authorization of the Pfizer-BioNTech COVID-19 Vaccine

Testimony Delivered to the Vaccines and Related Biological Products Advisory Committee

FDA Meeting – Development, authorization and licensure of vaccines to prevent COVID-19

By Sarah Christopherson | Oct 22, 2020 | Comments Off on FDA Meeting – Development, authorization and licensure of vaccines to prevent COVID-19

Testimony Delivered to the Vaccines and Related Biological Products Advisory Committee

FDA Comments — Office of Women’s Health Strategic Priorities

By Sarah Christopherson | Sep 8, 2020 | Comments Off on FDA Comments — Office of Women’s Health Strategic Priorities

Public comments urging the FDA’s Office of Women’s Health to ensure that women’s needs are represented across FDA and in the agency’s research, education, and public outreach.

It’s Time to #MailTheAbortionPill

By Sarah Christopherson | Jul 1, 2020 | Comments Off on It’s Time to #MailTheAbortionPill

Patients are turning to telehealth appointments and online pharmacies for routine medical care during the COVID-19 outbreak without having to leave their homes. But for most pregnant people seeking safe and effective abortion pills, the FDA has created a Byzantine set of rules that delay or block access to care.

Lift Unnecessary Restrictions: Access to Medication Abortion During the COVID-19 Pandemic

By M. Isabelle Chaudry | Jun 1, 2020 | Comments Off on Lift Unnecessary Restrictions: Access to Medication Abortion During the COVID-19 Pandemic

The NWHN is calling on the FDA to lift politically motivated, medically unnecessary restrictions on the abortion pill right now and let pregnant people receive the abortion pill through the mail so that they can get the pill where they take the pill, at home.

The FDA’s Convoluted Stance on Abortion Pills Doesn’t Protect Patients — It Endangers Them

By Sarah Christopherson | May 8, 2020 | Comments Off on The FDA’s Convoluted Stance on Abortion Pills Doesn’t Protect Patients — It Endangers Them

The FDA says pregnant people can meet with their doctors remotely and have their abortion at home — but first, they must travel during a global pandemic just to pick up their pills.

COVID-19 and Experimental Drugs: Health Information

By NWHN Staff | Apr 9, 2020 | Comments Off on COVID-19 and Experimental Drugs: Health Information

As the United States nears the peak of the COVID-19 pandemic, it is natural to hope for treatments that can save lives. But when experimental drugs are promoted by a president who has consistently eschewed and misrepresented science, consumers and patients have to exercise caution.

Permanently Lift Restrictions on the Abortion Pill!

By NWHN Staff | Mar 31, 2020 | Comments Off on Permanently Lift Restrictions on the Abortion Pill!

We’re calling on the FDA to let pregnant people receive the abortion pill through the mail so that they can get the pill where they take the pill — at home!